Milestone Pharmaceuticals Inc. Share Price
Equities
MIST
CA59935V1076
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.54 USD | -2.53% | -6.10% | -7.78% |
Sales 2024 * | - | Sales 2025 * | 13.5M 1.08B | Capitalization | 96.6M 7.73B |
---|---|---|---|---|---|
Net income 2024 * | -59M -4.72B | Net income 2025 * | -82M -6.56B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 7.16 x |
P/E ratio 2024 * |
-1.34
x | P/E ratio 2025 * |
-1
x | Employees | 47 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.37% |
Latest transcript on Milestone Pharmaceuticals Inc.
1 day | -2.53% | ||
1 week | -6.10% | ||
Current month | -13.97% | ||
1 month | -14.44% | ||
6 months | -32.46% | ||
Current year | -7.78% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Oliveto
CEO | Chief Executive Officer | 56 | 06/03/17 |
Amit Hasija
DFI | Director of Finance/CFO | 51 | 08/09/19 |
Anita Holz
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Seth Fischer
BRD | Director/Board Member | 68 | 20/03/23 |
Joseph Oliveto
CEO | Chief Executive Officer | 56 | 06/03/17 |
Debra Liebert
BRD | Director/Board Member | 67 | 31/05/15 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.54 | -2.53% | 469,849 |
25/04/24 | 1.58 | -4.82% | 253,033 |
24/04/24 | 1.66 | -2.35% | 48,684 |
23/04/24 | 1.7 | +4.29% | 90,452 |
22/04/24 | 1.63 | -0.61% | 34,803 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.78% | 96.6M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- MIST Stock